Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Koichiro Yamamoto; Kaoru Nakamura; Hideharu Hagiya; Fumio Otsuka

doi:10.1002/ccr3.4858

Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Clin Case Rep. 2021 Sep 21;9(9):e04858. doi: 10.1002/ccr3.4858. eCollection 2021 Sep.

Authors

Koichiro Yamamoto¹, Kaoru Nakamura², Hideharu Hagiya¹, Fumio Otsuka¹

Affiliations

¹ Department of General Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.
² Center for Graduate Medical Education Okayama University Hospital Okayama Japan.

Abstract

COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

Keywords: SARS‐CoV‐2; candidemia; coronavirus disease 2019; corticosteroid; tocilizumab.